389 related articles for article (PubMed ID: 35012849)
1. Chromatin basis of the senescence-associated secretory phenotype.
Hao X; Wang C; Zhang R
Trends Cell Biol; 2022 Jun; 32(6):513-526. PubMed ID: 35012849
[TBL] [Abstract][Full Text] [Related]
2. Cellular senescence and senescence-associated secretory phenotype via the cGAS-STING signaling pathway in cancer.
Loo TM; Miyata K; Tanaka Y; Takahashi A
Cancer Sci; 2020 Feb; 111(2):304-311. PubMed ID: 31799772
[TBL] [Abstract][Full Text] [Related]
3. Potential Regulators of the Senescence-Associated Secretory Phenotype During Senescence and Aging.
Han X; Lei Q; Xie J; Liu H; Li J; Zhang X; Zhang T; Gou X
J Gerontol A Biol Sci Med Sci; 2022 Nov; 77(11):2207-2218. PubMed ID: 35524726
[TBL] [Abstract][Full Text] [Related]
4. The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis?
Ohtani N
Inflamm Regen; 2022 Apr; 42(1):11. PubMed ID: 35365245
[TBL] [Abstract][Full Text] [Related]
5. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence.
Glück S; Guey B; Gulen MF; Wolter K; Kang TW; Schmacke NA; Bridgeman A; Rehwinkel J; Zender L; Ablasser A
Nat Cell Biol; 2017 Sep; 19(9):1061-1070. PubMed ID: 28759028
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic chromatin triggers inflammation in senescence and cancer.
Dou Z; Ghosh K; Vizioli MG; Zhu J; Sen P; Wangensteen KJ; Simithy J; Lan Y; Lin Y; Zhou Z; Capell BC; Xu C; Xu M; Kieckhaefer JE; Jiang T; Shoshkes-Carmel M; Tanim KMAA; Barber GN; Seykora JT; Millar SE; Kaestner KH; Garcia BA; Adams PD; Berger SL
Nature; 2017 Oct; 550(7676):402-406. PubMed ID: 28976970
[TBL] [Abstract][Full Text] [Related]
7. TXNRD1 drives the innate immune response in senescent cells with implications for age-associated inflammation.
Hao X; Zhao B; Towers M; Liao L; Monteiro EL; Xu X; Freeman C; Peng H; Tang HY; Havas A; Kossenkov AV; Berger SL; Adams PD; Speicher DW; Schultz D; Marmorstein R; Zaret KS; Zhang R
Nat Aging; 2024 Feb; 4(2):185-197. PubMed ID: 38267705
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic chromatin fragments-from mechanisms to therapeutic potential.
Miller KN; Dasgupta N; Liu T; Adams PD; Vizioli MG
Elife; 2021 Jan; 10():. PubMed ID: 33512316
[TBL] [Abstract][Full Text] [Related]
9. Senescence-associated extracellular vesicle release plays a role in senescence-associated secretory phenotype (SASP) in age-associated diseases.
Tanaka Y; Takahashi A
J Biochem; 2021 Mar; 169(2):147-153. PubMed ID: 33002139
[TBL] [Abstract][Full Text] [Related]
10. Autolysosomal degradation of cytosolic chromatin fragments antagonizes oxidative stress-induced senescence.
Han X; Chen H; Gong H; Tang X; Huang N; Xu W; Tai H; Zhang G; Zhao T; Gong C; Wang S; Yang Y; Xiao H
J Biol Chem; 2020 Apr; 295(14):4451-4463. PubMed ID: 32047109
[TBL] [Abstract][Full Text] [Related]
11. Link Between Senescence and Cell Fate: Senescence-Associated Secretory Phenotype and Its Effects on Stem Cell Fate Transition.
Pan Y; Gu Z; Lyu Y; Yang Y; Chung M; Pan X; Cai S
Rejuvenation Res; 2022 Aug; 25(4):160-172. PubMed ID: 35658548
[TBL] [Abstract][Full Text] [Related]
12. cGAS-STING pathway as a potential trigger of immunosenescence and inflammaging.
Schmitz CRR; Maurmann RM; Guma FTCR; Bauer ME; Barbé-Tuana FM
Front Immunol; 2023; 14():1132653. PubMed ID: 36926349
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence.
Vizioli MG; Liu T; Miller KN; Robertson NA; Gilroy K; Lagnado AB; Perez-Garcia A; Kiourtis C; Dasgupta N; Lei X; Kruger PJ; Nixon C; Clark W; Jurk D; Bird TG; Passos JF; Berger SL; Dou Z; Adams PD
Genes Dev; 2020 Mar; 34(5-6):428-445. PubMed ID: 32001510
[TBL] [Abstract][Full Text] [Related]
14. HMGB2 orchestrates the chromatin landscape of senescence-associated secretory phenotype gene loci.
Aird KM; Iwasaki O; Kossenkov AV; Tanizawa H; Fatkhutdinov N; Bitler BG; Le L; Alicea G; Yang TL; Johnson FB; Noma KI; Zhang R
J Cell Biol; 2016 Nov; 215(3):325-334. PubMed ID: 27799366
[TBL] [Abstract][Full Text] [Related]
15. Dynamic and scalable assessment of the senescence-associated secretory phenotype (SASP).
Malaquin N; Rodier F
Methods Cell Biol; 2024; 181():181-195. PubMed ID: 38302239
[TBL] [Abstract][Full Text] [Related]
16. Senescence and the SASP: many therapeutic avenues.
Birch J; Gil J
Genes Dev; 2020 Dec; 34(23-24):1565-1576. PubMed ID: 33262144
[TBL] [Abstract][Full Text] [Related]
17. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
Malaquin N; Martinez A; Rodier F
Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence and the tumour microenvironment.
Takasugi M; Yoshida Y; Ohtani N
Mol Oncol; 2022 Sep; 16(18):3333-3351. PubMed ID: 35674109
[TBL] [Abstract][Full Text] [Related]
19. The role of cellular senescence and SASP in tumour microenvironment.
Takasugi M; Yoshida Y; Hara E; Ohtani N
FEBS J; 2023 Mar; 290(5):1348-1361. PubMed ID: 35106956
[TBL] [Abstract][Full Text] [Related]
20. Aging-related decrease of histone methyltransferase SUV39H1 in adipose-derived stem cells enhanced SASP.
Li R; Teng Y; Guo Y; Ren J; Li R; Luo H; Chen D; Feng Z; Fu Z; Zou X; Wang W; Zhou C
Mech Ageing Dev; 2023 Oct; 215():111868. PubMed ID: 37666472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
